Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Kodvanj

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Medical Genetics. Part A|September 21, 2022
Possible marfanoid habitus of Cesare Alessandro Scaglia di Verrua evidenced in portraits of Sir Anthony van Dyck?Jan Homolak, Ivan Kodvanj
European Journal of Clinical Pharmacology|March 24, 2023
Outpatients prescribed with fluvoxamine around the time of COVID-19 diagnosis are not at a reduced risk of subsequent hospitalization and death compared to their non-prescribed peers: population-based matched cohort studyVladimir Trkulja, Ivan Kodvanj
Glycobiology|December 21, 2020
Immunoglobulin G glycome and severity of COVID-19: more likely a quantification of bias than a true association. A comment on Petrović et al., "Composition of the immunoglobulin G glycome associates with the severity of COVID-19"Vladimir Trkulja, Ivan Kodvanj, Jan Homolak
Clinical Drug Investigation|February 19, 2021
An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19Jan Homolak, Ivan Kodvanj, Vladimir Trkulja
British Journal of Clinical Pharmacology|September 12, 2022
People exposed to proton-pump inhibitors shortly preceding COVID-19 diagnosis are not at an increased risk of subsequent hospitalizations and mortality: A nationwide matched cohort studyIvan Kodvanj, Jan Homolak, Vladimir Trkulja
Scientometrics|February 7, 2022
Publishing of COVID-19 preprints in peer-reviewed journals, preprinting trends, public discussion and quality issuesIvan Kodvanj, Jan Homolak, Davor Virag, et al.
The Journal of Biological Chemistry|August 22, 2019
The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 via pyrimidine depletionVilma Dembitz, Barbara Tomic, Ivan Kodvanj, et al.
BMC Cancer|November 12, 2020
5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blastsVilma Dembitz, Hrvoje Lalic, Ivan Kodvanj, et al.
Molecular Nutrition & Food Research|August 28, 2021
Is Galactose a Hormetic Sugar? An Exploratory Study of the Rat Hippocampal Redox Regulatory NetworkJan Homolak, Ana Babic Perhoc, Ana Knezovic, et al.
Methodsx|January 10, 2022
Nitrocellulose redox permanganometry: A simple method for reductive capacity assessmentJan Homolak, Ivan Kodvanj, Ana Babic Perhoc, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Medical Genetics. Part A|September 21, 2022
Possible marfanoid habitus of Cesare Alessandro Scaglia di Verrua evidenced in portraits of Sir Anthony van Dyck?Jan Homolak, Ivan Kodvanj
European Journal of Clinical Pharmacology|March 24, 2023
Outpatients prescribed with fluvoxamine around the time of COVID-19 diagnosis are not at a reduced risk of subsequent hospitalization and death compared to their non-prescribed peers: population-based matched cohort studyVladimir Trkulja, Ivan Kodvanj
Glycobiology|December 21, 2020
Immunoglobulin G glycome and severity of COVID-19: more likely a quantification of bias than a true association. A comment on Petrović et al., "Composition of the immunoglobulin G glycome associates with the severity of COVID-19"Vladimir Trkulja, Ivan Kodvanj, Jan Homolak
Clinical Drug Investigation|February 19, 2021
An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19Jan Homolak, Ivan Kodvanj, Vladimir Trkulja
British Journal of Clinical Pharmacology|September 12, 2022
People exposed to proton-pump inhibitors shortly preceding COVID-19 diagnosis are not at an increased risk of subsequent hospitalizations and mortality: A nationwide matched cohort studyIvan Kodvanj, Jan Homolak, Vladimir Trkulja
Scientometrics|February 7, 2022
Publishing of COVID-19 preprints in peer-reviewed journals, preprinting trends, public discussion and quality issuesIvan Kodvanj, Jan Homolak, Davor Virag, et al.
The Journal of Biological Chemistry|August 22, 2019
The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 via pyrimidine depletionVilma Dembitz, Barbara Tomic, Ivan Kodvanj, et al.
BMC Cancer|November 12, 2020
5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blastsVilma Dembitz, Hrvoje Lalic, Ivan Kodvanj, et al.
Molecular Nutrition & Food Research|August 28, 2021
Is Galactose a Hormetic Sugar? An Exploratory Study of the Rat Hippocampal Redox Regulatory NetworkJan Homolak, Ana Babic Perhoc, Ana Knezovic, et al.
Methodsx|January 10, 2022
Nitrocellulose redox permanganometry: A simple method for reductive capacity assessmentJan Homolak, Ivan Kodvanj, Ana Babic Perhoc, et al.
Pageof 2